- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cumberland Pharmaceuticals Inc (CPIX)
Track today's live Cumberland (CPIX) share price, performance and key data on this page with our current NASDAQ:CPIX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Cumberland share price on the NASDAQ exchange. Use the dropdown to switch exchange for the CPIX share price, head to our technical summary section, which provides analysis on Cumberland share price buy/sell indicators using real-time data (or discuss the Cumberland (CPIX) stock price today with other investors in the Cumberland NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:CPIX share price (ISIN: US2307701092) to enhance your trading decisions with our free investment tools and resources.
What Is the Cumberland Pharmaceuticals Inc Share Price Today?
The Cumberland share price today is 8.460.
What Is the Stock Symbol for Cumberland Pharmaceuticals Inc
The stock symbol (or 'ticker') for Cumberland Pharmaceuticals Inc is "CPIX."
What Stock Exchange Does Cumberland Pharmaceuticals Inc Trade On?
Cumberland Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Cumberland Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Cumberland (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:CPIX share price (ISIN: US2307701092) to enhance your trading decisions with our free investment tools and resources.
What Is the Cumberland Pharmaceuticals Inc Share Price Today?
The Cumberland share price today is 8.460.
What Is the Stock Symbol for Cumberland Pharmaceuticals Inc
The stock symbol (or 'ticker') for Cumberland Pharmaceuticals Inc is "CPIX."
What Stock Exchange Does Cumberland Pharmaceuticals Inc Trade On?
Cumberland Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Cumberland Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Cumberland (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.440
9.160
52 wk Range
1.850
9.280
Unusual Post-Market activity
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.4409.160
52 wk Range
1.8509.280
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(17.34%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(17.34%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CPIX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High return over the last year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Cumberland Pharmaceuticals Inc Earnings Call Summary for Q2/2026
- Cumberland completed sale of commercial brands to Apotex for $100M upfront, $11M deferred, pivoting to development-stage biopharmaceutical company.
- Q2 2026 operating loss of $3.1M, net loss of $4.1M; paid $22M special dividend ($1.50/share) and retired $5.2M credit line with proceeds.
- Company projects cash runway exceeding five years with $50M+ in reserves; shares rose 8.22% to $7.77, then fell 8.11% after-hours to $7.14.
- Ifetroban pipeline advancing: DMD FDA meeting expected fall 2026, systemic sclerosis and IPF interim results due 2026, oncology under evaluation.
- Management emphasizes strategic shift from commercial to innovation-focused model; 99% shareholder approval reflects confidence in clinical execution strategy.
Last Updated: 04/08/2026, 22:34
Read Full TranscriptEarnings
Latest Release
04/08/2026
EPS / Forecast
-0.20 / --
Revenue / Forecast
166.45M / --
Compare CPIX to Peers and Sector
Metrics to compare | CPIX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCPIXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −39.6x | −4.0x | −0.4x | |
PEG Ratio | 0.15 | −0.05 | 0.00 | |
Price/Book | 7.3x | −0.7x | 2.6x | |
Price / LTM Sales | 2.9x | 2.5x | 3.1x | |
Upside (Analyst Target) | - | 134.2% | 47.7% | |
Fair Value Upside | Unlock | 8.3% | 6.5% | Unlock |
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The company has a strategic alliance agreement with WinHealth Pharma Group Co. Limited. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cumberland (NASDAQ: CPIX) Share Price Today?
The Cumberland stock price today is 8.460 USD.
What Stock Exchange Does Cumberland (CPIX) Trade On?
Cumberland is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Cumberland?
The stock symbol (also called a 'ticker') for Cumberland is "CPIX."
Does Cumberland Pay Dividends? What’s The Current CPIX Dividend Yield?
Yes, CPIX Pays Dividends to its Shareholders. The current Cumberland dividend yield is 17.34%.
What Is the Current Cumberland Market Capitalisation?
As of today, Cumberland (NASDAQ: CPIX) market cap is 126.760M USD.
What Is Cumberland's (CPIX) Earnings Per Share (TTM)?
The Cumberland EPS is currently -0.221 (Trailing Twelve Months).
When Is the Next Cumberland Earnings Date?
Cumberland's next earnings report will be released on 10/11/2026.
Is CPIX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Cumberland moving averages and other technical indicators, the daily buy/sell signal for CPIX stock is Strong Buy.
How Many Times Has Cumberland Stock Split?
Cumberland has split 0 times. (See the CPIX stock split history page for full effective split date and price information.)
How Many Employees Does Cumberland Have?
Cumberland has 88 employees, based on their latest Companies House report.
What is the current trading status of Cumberland (NASDAQ: CPIX)?
As of 31/08/2026, Cumberland (CPIX) is trading at a share price of 8.460 USD, with a previous close of 8.650 USD. The stock has fluctuated within a day range of 8.440 USD to 9.160 USD, while its 52-week range spans from 1.850 USD to 9.280 USD.
What Is the CPIX Premarket Price?
CPIX's last pre-market stock price is 8.800 USD. The pre-market share volume is 210.000, and the stock has decreased by 0.150, or 1.730%.
What Is the CPIX After Hours Price?
CPIX's last after hours stock price is 7.990 USD, the stock has decreased by -0.470, or -5.560%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.